Published in Biotechnol Biotechnol Equip on July 24, 2014
Cancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in Cancer. Front Cell Dev Biol (2016) 0.76
Light/Dark Shifting Promotes Alcohol-Induced Colon Carcinogenesis: Possible Role of Intestinal Inflammatory Milieu and Microbiota. Int J Mol Sci (2016) 0.75
Obesity and metabolic syndrome in circadian Clock mutant mice. Science (2005) 12.66
Mop3 is an essential component of the master circadian pacemaker in mammals. Cell (2000) 8.72
Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature (1999) 7.86
Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science (1994) 7.83
Positional cloning of the mouse circadian clock gene. Cell (1997) 7.79
A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci (2003) 6.30
An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science (2001) 6.07
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature (2010) 5.97
Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci U S A (1999) 4.62
Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature (2002) 3.75
Photic induction of mPer1 and mPer2 in cry-deficient mice lacking a biological clock. Science (1999) 3.42
Loss of circadian behavioral rhythms and per RNA oscillations in the Drosophila mutant timeless. Science (1994) 3.24
The transcriptional repressor DEC2 regulates sleep length in mammals. Science (2009) 3.12
Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A (2005) 2.95
Reduced cancer incidence among the blind. Epidemiology (1998) 2.73
Targeted disruption of the mPer3 gene: subtle effects on circadian clock function. Mol Cell Biol (2000) 2.69
Lack of food anticipation in Per2 mutant mice. Curr Biol (2006) 2.47
Night work and risk of breast cancer. Epidemiology (2006) 2.30
Circadian variation in the timing of stroke onset: a meta-analysis. Stroke (1998) 2.22
Light at night and melatonin have opposite effects on breast cancer tumors in mice assessed by growth rates and global DNA methylation. Chronobiol Int (2013) 2.05
Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int (2008) 2.04
Cancer chronotherapy: principles, applications, and perspectives. Cancer (2003) 2.00
Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med (2012) 1.98
Cellular senescence impairs circadian expression of clock genes in vitro and in vivo. Circ Res (2006) 1.68
Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain (2004) 1.63
Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes (2014) 1.62
Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY) (2011) 1.61
Circadian clock characteristics are altered in human thyroid malignant nodules. J Clin Endocrinol Metab (2013) 1.47
Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev (2005) 1.47
Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One (2010) 1.45
Post-translational regulation of circadian transcriptional CLOCK(NPAS2)/BMAL1 complex by CRYPTOCHROMES. Cell Cycle (2006) 1.43
Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J Biol Rhythms (2011) 1.36
Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle (2008) 1.35
Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci U S A (2009) 1.35
Circadian rhythm disruption in cancer biology. Mol Med (2012) 1.31
The circadian clock protein BMAL1 is necessary for fertility and proper testosterone production in mice. J Biol Rhythms (2008) 1.30
CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem (2000) 1.27
Developmental and reproductive performance in circadian mutant mice. Hum Reprod (2005) 1.26
A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res (2003) 1.26
Tumor suppression and circadian function. J Biol Rhythms (2007) 1.26
Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol (2011) 1.21
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer (2007) 1.21
Deficiency of circadian protein CLOCK reduces lifespan and increases age-related cataract development in mice. Aging (Albany NY) (2010) 1.19
Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". FASEB J (2006) 1.16
Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem (2009) 1.14
Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep (2011) 1.12
The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int (2009) 1.11
Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.10
Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst (2013) 1.08
"Feeding time" for the brain: a matter of clocks. J Physiol Paris (2007) 1.08
Reproductive performance in female Clock Delta19 mutant mice. Reprod Fertil Dev (2004) 1.05
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat (2008) 1.03
Circadian variation and triggering of cardiovascular events. Vasc Med (1999) 1.03
DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Cancer Res (1993) 1.02
Disturbance of circadian gene expression in breast cancer. Virchows Arch (2009) 0.99
Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer (2001) 0.98
Tumor growth suppression in vivo by overexpression of the circadian component, PER2. Genes Cells (2010) 0.98
Total visual blindness is protective against breast cancer. Cancer Causes Control (2009) 0.98
A polymorphism at the 3'-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.97
Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment. Cancer Causes Control (2006) 0.96
Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res (2013) 0.96
Time-of-day affects expression of hippocampal markers for ischemic damage induced by global ischemia. Exp Neurol (2007) 0.95
Altered expression of the clock gene machinery in kidney cancer patients. Biomed Pharmacother (2011) 0.94
Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer (2000) 0.93
The circadian clock and tumor suppression by mammalian period genes. Methods Enzymol (2005) 0.92
Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. Int J Clin Exp Pathol (2014) 0.91
Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma. Br J Cancer (2002) 0.91
Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol (2013) 0.90
Biological timing and the clock metaphor: oscillatory and hourglass mechanisms. Chronobiol Int (2001) 0.89
Does disruption of circadian rhythms contribute to beta-cell failure in type 2 diabetes? Curr Diab Rep (2014) 0.89
Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol (2009) 0.89
Traumatic brain injury-induced dysregulation of the circadian clock. PLoS One (2012) 0.89
Docetaxel chronopharmacology in mice. Cancer Res (1998) 0.88
Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One (2012) 0.88
Are some melanomas caused by artificial light? Med Hypotheses (2010) 0.87
Tumor-based rhythms of anticancer efficacy in experimental models. Chronobiol Int (2002) 0.86
Association of the clock genes polymorphisms with colorectal cancer susceptibility. J Surg Oncol (2013) 0.85
Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One (2013) 0.85
Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. Mol Biol Rep (2013) 0.83
Circadian and ultradian cytokinetic rhythms of spontaneous human cancer. Ann N Y Acad Sci (1991) 0.82
Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia. Curr Drug Targets (2006) 0.82
Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg (2012) 0.81
Bedtime misalignment and progression of breast cancer. Chronobiol Int (2013) 0.80
Telomerase reconstitution contributes to resetting of circadian rhythm in fibroblasts. Mol Cell Biochem (2008) 0.79
Influences of the circadian clock on neuronal susceptibility to excitotoxicity. Front Physiol (2013) 0.78
Repair pattern in the beta-globin gene cluster of human fibroblasts after ultraviolet irradiation. Eur J Biochem (1997) 0.78
What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part II - information content and validity of biomarkers for individual repair capacity in the assessment of outcomes of anticancer therapy. Biotechnol Biotechnol Equip (2014) 0.77
Increased neuronal injury in clock gene Per-1 deficient-mice after cerebral ischemia. Curr Neurovasc Res (2013) 0.76
Circadian and homeostatic changes of sleep-wake and quality of life in stroke: implications for neurorehabilitation. NeuroRehabilitation (2013) 0.76